Mercator’s micro-infusion device delivers drugs directly through blood vessel walls and into adventital tissues
Mercator MedSystems
August 2022
California, USA
£200,000.-
In selective areas of peripheral and coronary* vessels, the Micro-Infusion Device is intended for the infusion of diagnostic and therapeutic agents into the vessel wall or perivascular area, including local-acting anti-inflammatory agents to treat local inflammation. The Micro-Infusion Device is also intended for the infusion of diagnostic and therapeutic agents intraluminally.
The Micro-Infusion Device is indicated for the infusion of anti-inflammatory agents such as dexamethasone sodium phosphate to reduce vascular inflammation associated with endovascular revascularization.
Odio ultrices feugiat habitasse eu porta diam tortor. Leo et nunc risus senectus suscipit. Duis luctus cubilia diam sagittis suspendisse praesent. A nisl habitant potenti turpis dis inceptos magnis class.
Odio ultrices feugiat habitasse eu porta diam tortor. Leo et nunc risus senectus suscipit. Duis luctus cubilia diam sagittis suspendisse praesent. A nisl habitant potenti turpis dis inceptos magnis class.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
If you are seeking specialist dedication for your brand here in Europe we welcome your correspondence.